Bioequivalence is a term in pharmacokinetics used to assess the expected in-vivo biological equivalence of two propriety preparations of a drug. The comparison is usually between Innovator and generic drugs.
In Makin Research Center, we have all facilities and equipment required to undergo steps of Bioequivalence study (LC/MS-MS, HPLC-UV Photo Diode Array techniques).
MRC can assist the sponsor in the design, analysis and interpretation of study data. Our expert biostatisticians have broad experience in various aspects of clinical trials within the drug development arena, from sample size calculation and design issues at the planning stage, to analyzing, displaying and interpreting data in the final stages of the study.